Long COVID prevalence high in Scandinavians with severe COVID-19

A collaborative study involving researchers from Karolinska Institutet has charted the prevalence of severe physical symptom burden amongst Scandinavians for up to two years after a SARS-CoV-2 infection.

Serotonin levels are depleted in long Covid patients, study says, pointing to a potential cause for ‘brain fog’

If you’ve been following the mystery of long Covid since it emerged in 2020, you’ll recall interferons and serotonin have been clues from the start

October 16, 2023

Early metformin therapy falls short in curbing gestational diabetes woes

In a significant randomized clinical trial, early metformin therapy was tested for its potential to lessen insulin dependence and enhance glycemic control in gestational diabetes-afflicted

October 4, 2023

Leo Pharma agrees to acquire Timber Pharmaceuticals

TMB-001 is intended for the treatment of congenital ichthyosis, a rare skin condition. Credit: Kwangmoozaa / Shutterstock.com. Leo Pharma has entered an agreement for the acquisition of

August 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.